CME Group Inc. $CME Shares Sold by Heritage Investors Management Corp

Heritage Investors Management Corp trimmed its holdings in shares of CME Group Inc. (NASDAQ:CME) by 10.2% during the second quarter, according to its most recent Form 13F filing with the SEC. The firm owned 1,010 shares of the financial services provider’s stock after selling 115 shares during the period. Heritage Investors Management Corp’s holdings in CME Group were worth $278,000 as of its most recent SEC filing.

Other hedge funds have also recently bought and sold shares of the company. Webster Bank N. A. lifted its position in CME Group by 206.9% in the 2nd quarter. Webster Bank N. A. now owns 89 shares of the financial services provider’s stock valued at $25,000 after purchasing an additional 60 shares during the last quarter. Highline Wealth Partners LLC lifted its position in CME Group by 84.3% in the 2nd quarter. Highline Wealth Partners LLC now owns 94 shares of the financial services provider’s stock valued at $26,000 after purchasing an additional 43 shares during the last quarter. Wayfinding Financial LLC bought a new stake in CME Group in the 1st quarter valued at about $25,000. Cornerstone Planning Group LLC lifted its position in CME Group by 122.2% in the 1st quarter. Cornerstone Planning Group LLC now owns 100 shares of the financial services provider’s stock valued at $26,000 after purchasing an additional 55 shares during the last quarter. Finally, Trifecta Capital Advisors LLC lifted its position in CME Group by 59.2% in the 2nd quarter. Trifecta Capital Advisors LLC now owns 113 shares of the financial services provider’s stock valued at $31,000 after purchasing an additional 42 shares during the last quarter. 87.75% of the stock is currently owned by institutional investors.

Insider Buying and Selling at CME Group

In other news, General Counsel Jonathan L. Marcus sold 392 shares of CME Group stock in a transaction that occurred on Thursday, September 18th. The shares were sold at an average price of $262.00, for a total value of $102,704.00. Following the transaction, the general counsel directly owned 7,851 shares of the company’s stock, valued at $2,056,962. This trade represents a 4.76% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, insider Timothy Francis Mccourt sold 379 shares of the business’s stock in a transaction that occurred on Tuesday, September 16th. The shares were sold at an average price of $259.83, for a total transaction of $98,475.57. Following the sale, the insider owned 9,508 shares in the company, valued at $2,470,463.64. This represents a 3.83% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last 90 days, insiders sold 13,043 shares of company stock worth $3,527,956. 0.30% of the stock is currently owned by company insiders.

CME Group Stock Performance

Shares of CME opened at $262.89 on Friday. The firm’s 50 day moving average is $265.91 and its 200-day moving average is $272.01. The stock has a market capitalization of $94.74 billion, a P/E ratio of 25.47, a P/E/G ratio of 4.41 and a beta of 0.41. The company has a debt-to-equity ratio of 0.12, a current ratio of 1.02 and a quick ratio of 1.02. CME Group Inc. has a 12-month low of $213.94 and a 12-month high of $290.79.

CME Group (NASDAQ:CME) last announced its quarterly earnings data on Wednesday, October 22nd. The financial services provider reported $2.68 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.63 by $0.05. The company had revenue of $1.54 billion for the quarter, compared to analysts’ expectations of $1.56 billion. CME Group had a net margin of 58.84% and a return on equity of 14.61%. The business’s revenue was down 3.0% compared to the same quarter last year. During the same quarter in the previous year, the company posted $2.68 EPS. Equities research analysts anticipate that CME Group Inc. will post 10.49 EPS for the current fiscal year.

CME Group Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Thursday, September 25th. Stockholders of record on Tuesday, September 9th were paid a $1.25 dividend. The ex-dividend date of this dividend was Tuesday, September 9th. This represents a $5.00 annualized dividend and a dividend yield of 1.9%. CME Group’s payout ratio is currently 48.45%.

Analysts Set New Price Targets

Several analysts recently weighed in on CME shares. UBS Group cut their price objective on shares of CME Group from $285.00 to $280.00 and set a “neutral” rating on the stock in a research report on Thursday, October 23rd. Raymond James Financial lowered their target price on shares of CME Group from $309.00 to $307.00 and set an “outperform” rating on the stock in a research note on Monday, October 13th. Deutsche Bank Aktiengesellschaft raised shares of CME Group from a “hold” rating to a “buy” rating and raised their target price for the company from $266.00 to $300.00 in a research note on Thursday, October 23rd. Morgan Stanley raised their target price on shares of CME Group from $312.00 to $314.00 and gave the company an “overweight” rating in a research note on Thursday, October 23rd. Finally, Weiss Ratings reissued a “buy (b)” rating on shares of CME Group in a research note on Wednesday, October 8th. Eight equities research analysts have rated the stock with a Buy rating, six have issued a Hold rating and three have assigned a Sell rating to the company. According to MarketBeat.com, the company presently has an average rating of “Hold” and an average price target of $284.53.

About CME Group

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.